Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link

Sorafenib in advanced hepatocellular carcinoma

Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097 · see citing works

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717 · see citing works

SEER Cancer Statistics Review, 1975-2003

Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404 · see citing works

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works

Inflammation and cancer: back to Virchow?

Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · see citing works

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults

Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · see citing works

Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey

Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698 · see citing works

A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib

Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974 · see citing works

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832 · see citing works

Sorafenib in Advanced Hepatocellular Carcinoma

정, 재. (2008) · Cited by 5,606 · see citing works

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228 · see citing works

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · see citing works

Abdominal obesity and metabolic syndrome

Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · see citing works

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · see citing works

Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,676 · see citing works

Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,413 · see citing works

Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference

Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,155 · see citing works

Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old

Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,115 · see citing works

The utility of radiological imaging in nonalcoholic fatty liver disease

Saadeh, S. N., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M. E., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,112 · see citing works

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106 · see citing works

Body Weight and Mortality among Women

Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 2,005 · see citing works

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

Chan, J. M., Stampfer, M. J., Giovannucci, E. L., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,992 · see citing works

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · see citing works

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B. J., ROSNER, B. A., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,822 · see citing works

Nonalcoholic fatty liver disease

Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,652 · see citing works

The Epidemiology of Obesity

Ogden, C. L., Yanovski, S. Z., Carroll, M. D., & Flegal, K. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.052 · Cited by 1,561 · see citing works

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · see citing works

Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults

Ford, E. S., Giles, W. H., & Mokdad, A. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2444 · Cited by 1,488 · see citing works

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473 · see citing works

The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States

Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07486.x · Cited by 1,359 · see citing works

Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #

Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,250 · see citing works

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

El‐Serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,232 · see citing works

Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease

Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138 · see citing works

Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3

Ma, J., Pollak, M., Giovannucci, E. L., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,118 · see citing works

Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women

Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 989 · see citing works

Overweight, obesity, and cancer risk

Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 930 · see citing works

Insulin resistance: a metabolic pathway to chronic liver disease

Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900 · see citing works

Dietary Guidelines for Americans, 2005

Mosocco, D. J. (2006) · Home Healthcare Now · doi:10.1097/00004045-200610000-00002 · Cited by 801 · see citing works

Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762 · see citing works

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08699.x · Cited by 728 · see citing works

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

Aithal, G. P., Thomas, J. A., Kaye, P. V., Lawson, A., Ryder, S. D., Spendlove, I., Austin, A. S., Freeman, J. G., Morgan, L., & Webber, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.047 · Cited by 721 · see citing works

A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 683 · see citing works

Metformin in non-alcoholic steatohepatitis.

Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682 · see citing works

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis

George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 655 · see citing works

Obesity, Regional Body Fat Distribution, and the Metabolic Syndrome in Older Men and Women

Goodpaster, B. H., Krishnaswami, S., Harris, T. B., Katsiaras, A., Kritchevsky, S. B., Simonsick, E. M., Nevitt, M., Holvoet, P., & Newman, A. B. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.777 · Cited by 637 · see citing works

Visceral fat: A key mediator of steatohepatitis in metabolic liver disease

van der Poorten, D. K., Milner, K.-L., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 633 · see citing works

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

Luedde, T., Beraza, N., Kotsikoris, V., Loo, G., Nenci, A., Vos, R. D., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 596 · see citing works

Estimating future hepatitis C morbidity, mortality, and costs in the United States

Wong, J. B., McQuillan, G. M., McHutchison, J. G., & Poynard, T. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.10.1562 · Cited by 566 · see citing works

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study

Poonawala, A., Nair, S. P., & Thuluvath, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.17894 · Cited by 566 · see citing works

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

Chen, C., Yang, H., Yang, W., Liu, C., Chen, P., You, S., Wang, L., Sun, C., Lu, S., Chen, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.073 · Cited by 544 · see citing works

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

Harnois, D. M. (2009) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79298-0 · Cited by 505 · see citing works

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years [Hepatology 1990; 11:74–80]

Caldwell, S. H., & Crespo, D. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.013 · Cited by 499 · see citing works

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 494 · see citing works

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial†‡§

Harrison, S. A., Fecht, W., Brunt, E. M., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22575 · Cited by 470 · see citing works

Concomitant Activation of the JAK/STAT, PI3K/AKT, and ERK Signaling Is Involved in Leptin-Mediated Promotion of Invasion and Migration of Hepatocellular Carcinoma Cells

Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., & Anania, F. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3075 · Cited by 468 · see citing works

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

Ratziu, V., Bonyhay, L., Martino, V. D., Charlotte, F., Cavallaro, L. G., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 461 · see citing works

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458 · see citing works

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

Allison, M., Wreghitt, T. G., Palmer, C., & Alexander, G. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80631-2 · Cited by 453 · see citing works

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study

Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J. A., Emick, D. M., Lok, A. S.-F., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 445 · see citing works

Human Body Composition and the Epidemiology of Chronic Disease

Baumgartner, R. N., Heymsfield, S. B., & Roche, A. F. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00124.x · Cited by 413 · see citing works

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease

Nobili, V., Manco, M., Vito, R. D., Ciommo, V. M. D., Comparcola, D., Sartorelli, M. R., Piemonte, F., Marcellini, M., & Angulo, P. (2008) · Hepatology · doi:10.1002/hep.22336 · Cited by 412 · see citing works

Leptin receptor–mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat

Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 385 · see citing works

Excess Risk of Primary Liver Cancer in Patients With Diabetes Mellitus

Adami, H., Chow, W.-H., Nyrén, O., Berne, C., Linet, M. S., Ekbom, A., Wolk, A., McLaughlin, J. K., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1472 · Cited by 373 · see citing works

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?

Chitturi, S., Farrell, G. C., Frost, L., Kriketos, A. D., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 363 · see citing works

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348 · see citing works

Physical inactivity, excess adiposity and premature mortality

Katzmarzyk, P. T., Janssen, I., & Ardern, C. I. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00120.x · Cited by 315 · see citing works

Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study

Hsing, A. W., Chua, S. C., Gao, Y., Gentzschein, E., Chang, L. J., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 295 · see citing works

Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes

El–Serag, H. B., Johnson, M. L., Hachem, C., & Morgana, R. O. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.053 · Cited by 291 · see citing works

Nonalcoholic Fatty Liver Disease

Adams, L. A., & Lindor, K. D. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.05.013 · Cited by 290 · see citing works

Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures

Zelber‐Sagi, S., Nitzan, D., Halpern, Z., & Oren, R. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01311.x · Cited by 289 · see citing works

Undertreatment of Obese Women Receiving Breast Cancer Chemotherapy

Griggs, J. J., Sorbero, M. E. S., & Lyman, G. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1267 · Cited by 289 · see citing works

Gastric Bypass Surgery Improves Metabolic and Hepatic Abnormalities Associated With Nonalcoholic Fatty Liver Disease

Klein, S., Mittendorfer, B., Eagon, J. C., Patterson, B. W., Grant, L. M., Feirt, N. M., Seki, E., Brenner, D. A., Korenblat, K., & McCrea, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.042 · Cited by 288 · see citing works

Impact of Prediagnosis Smoking, Alcohol, Obesity, and Insulin Resistance on Survival in Male Cancer Patients: National Health Insurance Corporation Study

Park, S. M., Lim, M. K., Shin, S. A., & Yun, Y. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0243 · Cited by 263 · see citing works

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†

Lutchman, G. A., Modi, A. A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M. G., Borg, B. B., Loomba, R. S., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 240 · see citing works

A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis

Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234 · see citing works

Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis

Browning, J. D., Kumar, K. S., Saboorian, M. H., & Thiele, D. L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04059.x · Cited by 227 · see citing works

Increasing Trends in Incidence of Overweight and Obesity over 5 Decades

Parikh, N. I., Pencina, M. J., Wang, T. J., Lanier, K. J., Fox, C. S., D’Agostino, R. B., & Vasan, R. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.004 · Cited by 213 · see citing works

Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia

Hyogo, H., Tazuma, S., Arihiro, K., Iwamoto, K., Nabeshima, Y., Inoue, M., Ishitobi, T., Nonaka, M., & Chayama, K. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.030 · Cited by 206 · see citing works

Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years

Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193 · see citing works

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis

Pekow, J. R., Bhan, A. K., Zheng, H., & Chung, R. T. (2007) · Cancer · doi:10.1002/cncr.22701 · Cited by 183 · see citing works

Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis

Sorrentino, P., D’Angelo, S., Ferbo, U., Micheli, P., Bracigliano, A., & Vecchione, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.09.011 · Cited by 182 · see citing works

Height and Body Mass Index in Relation to Total Mortality

Engeland, A., Bjørge, T., Selmer, R. M., & Tverdal, A. (2003) · Epidemiology · doi:10.1097/01.ede.0000047889.30616.73 · Cited by 175 · see citing works

A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men

Ma, J., Pollak, M., Giovannucci, E. L., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)90013-3 · Cited by 175 · see citing works

Is NASH underdiagnosed among African Americans?

Caldwell, S. H., Harris, D. M., Patrie, J. T., & Hespenheide, E. E. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05795.x · Cited by 160 · see citing works

The Evolution of Severe Steatosis After Bariatric Surgery Is Related to Insulin Resistance

Mathurin, P., Gonzalez, F., Kerdraon, O., Leteurtre, E., Arnalsteen, L., Hollebecque, A., Louvet, A., Dharancy, S., Cocq, P., Jany, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.024 · Cited by 157 · see citing works

Epidemiology of Hepatocellular Carcinoma in Hispanics in the United States

El‐Serag, H. B., Lau, M., Eschbach, K., Davila, J. A., & Goodwin, J. S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.18.1983 · Cited by 137 · see citing works

General and Abdominal Obesity and Survival among Young Women with Breast Cancer

Abrahamson, P. E., Gammon, M. D., Lund, M. J., Flagg, E. W., Porter, P. L., Stevens, J., Swanson, C. A., Brinton, L. A., Eley, J. W., & Coates, R. J. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0356 · Cited by 136 · see citing works

Ethnic differences in adiponectin levels

Hulver, M. W., Saleh, O., MacDonald, K. G., Pories, W. J., & Barakat, H. A. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.002 · Cited by 136 · see citing works

Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men

Yu, M., Shih, W., Lin, C., Liu, C., Jian, J.-W., Tsai, K., & Chen, C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1075 · Cited by 124 · see citing works

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Natural History?

Cotrim, H. P., Paraná, R., Braga, E., & Lyra, L. G. C. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03241.x · Cited by 121 · see citing works

Epidemic Inflammation: Pondering Obesity

Nathan, C. (2008) · Molecular Medicine · doi:10.2119/2008-00038.nathan · Cited by 118 · see citing works

Obesity and Risk of Cancer in Postmenopausal Korean Women

Song, Y., Sung, J., & Ha, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7867 · Cited by 118 · see citing works

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

Delgado‐Borrego, A., Casson, D. R., Schoenfeld, D., Somsouk, M., Terella, A. M., Jordan, S. H., Bhan, A. K., Baid‐Agrawal, S., Cosimi, A. B., Pascual, M. A., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000114283.04840.3a · Cited by 117 · see citing works

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon‐alpha, doxorubicin and 5‐fluorouracil chemotherapy

Leung, T. W. T., Tang, A. M. Y., Zee, B. C.-Y., Yu, S. C. H., Lai, P. B. S., Lau, W. Y., & Johnson, P. J. (2002) · Cancer · doi:10.1002/cncr.10236 · Cited by 112 · see citing works

Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables

PERRY, A. C., Applegate, B. E., Jackson, M. L., DePrima, S., Goldberg, R. B., Ross, R., Kempner, L., & Feldman, B. B. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.636 · Cited by 112 · see citing works

A case-control study of primary hepatocellular carcinoma in Taiwan

Lu, S., Lin, T., Chen, C., Chen, J. S., Liaw, Y., Chang, W., & Hsu, S. T. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9 · Cited by 111 · see citing works

A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma

de Lima, V. M. R., de Oliveira, C. P. M. S., Alves, V. A. F., Chammas, M. C., Oliveira, E. P., Stefano, J. T., de Mello, E. S., Cerri, G. G., Carrilho, F. J., & Caldwell, S. H. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.024 · Cited by 107 · see citing works

Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo

Rega‐Kaun, G., Kaun, C., Demyanets, S., Pfaffenberger, S., Rychli, K., Hohensinner, P. J., Kastl, S., Speidl, W. S., Weiss, T. W., Breuss, J. M., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143081 · Cited by 104 · see citing works

Impact of Diabetes on Recurrence of Hepatocellular Carcinoma after Surgical Treatment in Patients With Viral Hepatitis

Komura, T., Mizukoshi, E., Kita, Y., Sakurai, M., Takata, Y., Arai, K., Yamashita, T., Ohta, T., Shimizu, K., Nakamoto, Y., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01354.x · Cited by 85 · see citing works

Iron in NASH, chronic liver diseases and HCC: How much iron is too much?

Pietrangelo, A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.011 · Cited by 84 · see citing works

The Hepatitis B Virus X Protein Inhibits Secretion of Apolipoprotein B by Enhancing the Expression of N-Acetylglucosaminyltransferase III

Kang, S.-K., Chung, T., Lee, J.-Y., Lee, Y.-C., Morton, R. E., & Kim, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403176200 · Cited by 81 · see citing works

Increased Serum Leptin Levels and Over Expression of Leptin Receptors are Associated With the Invasion and Progression of Renal Cell Carcinoma

Horiguchi, A., Sumitomo, M., Asakuma, J., Asano, T., Zheng, R., Asano, T., Nanus, D. M., & Hayakawa, M. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.06.039 · Cited by 76 · see citing works

Effects of vitamin E treatment on peroxisome proliferator‐activated receptor‐α expression and insulin resistance in patients with non‐alcoholic steatohepatitis: results of a pilot study

Yakaryılmaz, F., Güliter, S., Savaş, B., Erdem, Ö., Ersoy, R., Erden, E., Akyol, G., Bozkaya, H., & Özeni̇rler, S. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01295.x · Cited by 75 · see citing works

Steatosis and hepatocellular carcinoma risk.

Smedile, A., & Bugianesi, E. (2006) · PubMed · Cited by 71 · see citing works

The global epidemic of obesity

Gill, T. P., & James, W. (1999) · Asia Pacific Journal of Clinical Nutrition · doi:10.1046/j.1440-6047.1999.00060.x · Cited by 58 · see citing works

Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma

Utsunomiya, T. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1553 · Cited by 57 · see citing works

Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?

Abou-Alfa, G. K., Amadori, D., Santoro, A., Figer, A., Grève, J. D., Lathia, C. D., Voliotis, D., Anderson, S., Moscovici, M., & Ricci, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4518 · Cited by 56 · see citing works

Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis: Table 1

Assy, N., Hussein, O., & Abassi, Z. A. (2007) · Gut · doi:10.1136/gut.2006.106021 · Cited by 46 · see citing works

Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy

Adams, L. A., & Angulo, P. G. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.08695.x · Cited by 30 · see citing works

Obesity and Microvascular Invasion in Hepatocellular Carcinoma

Siegel, A. B., Wang, S., Jacobson, J. S., Hershman, D. L., Lim, E. A., Yu, J. C., Ferrante, L. E., Devaraj, K. M., Remotti, H. E., Scrudato, S., et al. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.483500 · Cited by 28 · see citing works

Body Mass Index Influences Palpability but not Stage of Breast Cancer at Diagnosis

Chagpar, A. B., McMasters, K. M., Saul, J., Nurko, J., Martin, R. C. G., Scoggins, C. R., & Edwards, M. J. (2007) · The American Surgeon · doi:10.1177/000313480707300605 · Cited by 27 · see citing works

Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus‐associated hepatocellular carcinoma

Takuma, Y., Nouso, K., Makino, Y., Saito, S., Takayama, H., Takahara, M., Takahashi, H., Murakami, I., & TAKEUCHI, H. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01462.x · Cited by 23 · see citing works

Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy

Adams, L. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.001 · Cited by 22 · see citing works

New International Measuring Stick for Defining Obesity in Non-Europeans

Samaha, F. F. (2007) · Circulation · doi:10.1161/circulationaha.107.696260 · Cited by 18 · see citing works

Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin

Johnson, P. J., Alexopoulos, A., Johnson, R. D., & Williams, R. L. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80020-4 · Cited by 17 · see citing works

HLA-DQ Associations Distinguish Insulin-Resistant and Insulin-Sensitive Variants of NIDDM in Black Americans

Banerji, M. A., Norin, A. J., Chaiken, R. L., & Lebovitz, H. E. (1993) · Diabetes Care · doi:10.2337/diacare.16.2.429 · Cited by 14 · see citing works

Obesity and microvascular invasion in HCC

Siegel, A. B., Yu, J., Moss, J. J., Wang, S., Jacobson, J. S., Lim, E., Khungar, V., Ferrante, L., Scrudato, S., Brown, R. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4520 · Cited by 1 · see citing works

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection

Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,340 · see citing works

Non-alcoholic fatty liver disease: An expanded review

Benedict, M., & Zhang, X. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i16.715 · Cited by 754 · see citing works

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database

Welzel, T. M., Graubard, B. I., Zeuzem, S., El‐Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 539 · see citing works

Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G. M., Schlaak, J., Gerken, G., Syn, W., & Canbay, A. E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25797 · Cited by 519 · see citing works

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis

Kettner, N. M., Voicu, H., Finegold, M. J., Coarfa, C., Sreekumar, A., Putluri, N., Katchy, C. A., Lee, C., Moore, D. D., & Fu, L. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.007 · Cited by 508 · see citing works

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

Thomas, M. B., Jaffe, D., Choti, M. A., Belghiti, J., Curley, S. A., Fong, Y., Gores, G. J., Kerlan, R. K., Merle, P., O’Neil, B. H., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7805 · Cited by 394 · see citing works

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.042 · Cited by 324 · see citing works

Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends

Matter, M. S., Decaens, T., Andersen, J. B., & Thorgeirsson, S. S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.031 · Cited by 314 · see citing works

Changing trends in malignant transformation of hepatocellular adenoma

Farges, O., Ferreira, N., Dokmak, S., Belghiti, J., Bédossa, P., & Paradis, V. (2010) · Gut · doi:10.1136/gut.2010.222109 · Cited by 299 · see citing works

Induction of Epigenetic Alterations by Dietary and Other Environmental Factors

Mathers, J. C., Strathdee, G. R., & Relton, C. L. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00001-8 · Cited by 292 · see citing works

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

Kawamura, Y., Arase, Y., Ikeda, K., Seko, Y., Imai, N., Hosaka, T., Kobayashi, M., Saitoh, S., Sezaki, H., Akuta, N., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.327 · Cited by 280 · see citing works

Prevalence, gender, ethnic variations, and prognosis of NASH

Hashimoto, E., & Tokushige, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0311-8 · Cited by 264 · see citing works

A Review of the Alleged Health Hazards of Monosodium Glutamate

Zanfirescu, A., Ungurianu, A., Tsatsakis, A. M., Nițulescu, G. M., Kouretas, D., Veskoukis, A. S., Tsoukalas, D., Engin, A. B., Aschner, M., & Margina, D. M. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12448 · Cited by 288 · see citing works

The story of HCC in NAFLD : from epidemiology, across pathogenesis, to prevention and treatment

Margini, C., & Dufour, J. (2015) · Liver International · doi:10.1111/liv.13031 · Cited by 246 · see citing works

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease

Reddy, S. K., Steel, J. L., Chen, H., DeMateo, D. J., Cardinal, J. S., Behari, J., Humar, A., Marsh, W. J., Geller, D. A., & Tsung, A. (2011) · Hepatology · doi:10.1002/hep.25536 · Cited by 224 · see citing works

MDM2–p53 Pathway in Hepatocellular Carcinoma

Meng, X., Franklin, D. A., Dong, J., & Zhang, Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1446 · Cited by 216 · see citing works

Recent advances in nonalcoholic fatty liver disease

Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 218 · see citing works

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma

Younossi, Z. M., & Henry, L. L. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100305 · Cited by 218 · see citing works

Mitochondrial Protein Acylation and Intermediary Metabolism: Regulation by Sirtuins and Implications for Metabolic Disease

Newman, J. C., He, W., & Verdin, E. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.404863 · Cited by 207 · see citing works

Interaction of Occupational and Personal Risk Factors in Workforce Health and Safety

Schulte, P. A., Pandalai, S. P., Wulsin, V., & Chun, H. (2011) · American Journal of Public Health · doi:10.2105/ajph.2011.300249 · Cited by 206 · see citing works

Fate and Complex Pathogenic Effects of Dioxins and Polychlorinated Biphenyls in Obese Subjects before and after Drastic Weight Loss

Kim, M. J., Marchand, P., Hénégar, C., Antignac, J., Alili, R., Poitou, C., Bouillot, J., Basdevant, A., Bizec, B. L., Barouki, R., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002848 · Cited by 205 · see citing works

The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial

Mitjavila, M. T., Fandos, M., Salas‐Salvadó, J., Covas, M., Borrego, S., Estruch, R., Lamuela-Raventós, R. M., Corella, D., Martínez‐González, M. Á., Sánchez, J. M., et al. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.002 · Cited by 200 · see citing works

Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma

Sawada, N., Inoue, M., Iwasaki, M., Sasazuki, S., Shimazu, T., Yamaji, T., Takachi, R., Tanaka, Y., Mizokami, M., & Tsugane, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.018 · Cited by 196 · see citing works

The Role of Metformin in the Management of NAFLD

Mazza, A., Fruci, B., Garinis, G. A., Giuliano, S., Malaguarnera, R., & Belfiore, A. (2011) · Experimental Diabetes Research · doi:10.1155/2012/716404 · Cited by 184 · see citing works

Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice

Pogribny, I. P., Starlard‐Davenport, A., Tryndyak, V., Han, T., Ross, S. A., Rusyn, I., & Beland, F. A. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.113 · Cited by 185 · see citing works

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

Noureddin, M., & Rinella, M. E. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.012 · Cited by 181 · see citing works

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis

Salomao, M. A., Remotti, H. E., VAUGHAN, R. D., Siegel, A. B., Lefkowitch, J. H., & Moreira, R. K. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.07.005 · Cited by 180 · see citing works

Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES

Simon, T. G., Bonilla, H. F., Yan, P., Chung, R. T., & Butt, A. A. (2016) · Hepatology · doi:10.1002/hep.28506 · Cited by 179 · see citing works

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults

Borena, W., Strohmaier, S., Lukanova, A., Bjørge, T., Lindkvist, B., Hallmans, G., Edlinger, M., Stocks, T., Nagel, G., Manjer, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26338 · Cited by 177 · see citing works

Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets

Severi, T., van Malenstein, H., Verslype, C., & van Pelt, J. F. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.142 · Cited by 176 · see citing works

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma

Pogribny, I. P., & Rusyn, I. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.038 · Cited by 174 · see citing works

Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment

Granito, A., Muratori, L., Lalanne, C., Quarneti, C., Ferri, S., Guidi, M., Lenzi, M., & Muratori, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.2994 · Cited by 172 · see citing works

Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients

Nkontchou, G., Cosson, E., Aout, M., Mahmoudi, A., Bourcier, V., Charif, I., Ganne‐Carrié, N., Grando–Lemaire, V., Vicaut, É., Trinchet, J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2415 · Cited by 165 · see citing works

Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome

Jin, X., Moskophidis, D., & Mivechi, N. F. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.025 · Cited by 164 · see citing works

Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results from two prospective cohort studies

Simon, T. G., King, L. Y., Chong, D. Q., Nguyen, L. H., Ma, Y., VoPham, T., Giovannucci, E. L., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., et al. (2018) · Hepatology · doi:10.1002/hep.29660 · Cited by 160 · see citing works

Metabolic syndrome and hepatocellular carcinoma risk

Turati, F., Talamini, R., Pelucchi, C., Polesel, J., Franceschi, S., Crispo, A., Izzo, F., Vecchia, C. L., Boffetta, P., & Montella, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.492 · Cited by 159 · see citing works

Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy

Ajoolabady, A., Tang, D., Kroemer, G., & Ren, J. T. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01998-x · Cited by 154 · see citing works

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors

Dongiovanni, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12945 · Cited by 145 · see citing works

Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man

Schattenberg, J. M., & Galle, P. R. (2010) · Digestive Diseases · doi:10.1159/000282097 · Cited by 140 · see citing works

Non-alcoholic fatty liver disease associated with hepatocellular carcinoma

Dhamija, E., Paul, S. B., & Kedia, S. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1456_17 · Cited by 139 · see citing works

Recent advances in nonalcoholic fatty liver disease

Cheung, O., & Sanyal, A. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328337b0c4 · Cited by 139 · see citing works

The Association Between Metabolic Syndrome and Hepatocellular Carcinoma

Jinjuvadia, R., Patel, S., & Liangpunsakul, S. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182a030c4 · Cited by 132 · see citing works

Hepatocellular adenoma subtypes: the impact of overweight and obesity

Bioulac‐Sage, P., Taouji, S., Possenti, L., & Balabaud, C. P. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02786.x · Cited by 129 · see citing works

Obesity and gastrointestinal cancer

Donohoe, C. L., Pidgeon, G. P., Lysaght, J., & Reynolds, J. V. (2010) · British journal of surgery · doi:10.1002/bjs.7079 · Cited by 129 · see citing works

Clinical problems caused by obesity

Kyrou, I., Randeva, H. S., Barber, T., Tsigos, C., Kaltsas, G. A., & Weickert, M. O. (2022) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33841351 · Cited by 127 · see citing works

Experience with regorafenib in the treatment of hepatocellular carcinoma

Granito, A., Forgione, A., Marinelli, S., Renzulli, M., Ielasi, L., Sansone, V., Benevento, F., Piscaglia, F., & Tovoli, F. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211016959 · Cited by 126 · see citing works

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey

Tokushige, K., Hashimoto, E., Horie, Y., Taniai, M., & Higuchi, S. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0431-9 · Cited by 124 · see citing works

The changing scenario of hepatocellular carcinoma in Italy: an update

Garuti, F., Neri, A., Avanzato, F., Gramenzi, A., Rampoldi, D., Rucci, P., Farinati, F., Giannini, E. G., Piscaglia, F., Rapaccini, G. L., et al. (2020) · Liver International · doi:10.1111/liv.14735 · Cited by 122 · see citing works

Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?

Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 121 · see citing works

Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis

Bhayani, N. H., Hyder, O. N., Frederick, W., Schulick, R. D., Wolgang, C. L., Hirose, K., Edil, B. H., Herman, J. M., Choti, M. A., & Pawlik, T. M. (2012) · Surgery · doi:10.1016/j.surg.2012.05.037 · Cited by 116 · see citing works

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

Chettouh, H., Lequoy, M., Fartoux, L., Vigouroux, C., & Desbois-Mouthon, C. (2015) · Liver international (Print) · doi:10.1111/liv.12903 · Cited by 111 · see citing works

The Credible Role of Curcumin in Oxidative Stress-Mediated Mitochondrial Dysfunction in Mammals

Sathyabhama, M., Dharshini, L. C. P., Karthikeyan, A., Senthil, K., & Min, T. (2022) · Biomolecules · doi:10.3390/biom12101405 · Cited by 115 · see citing works

Mitochondrial sirtuins: Emerging roles in metabolic regulations, energy homeostasis and diseases

Parihar, P., Solanki, I., Mansuri, M. L., & Parihar, M. S. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.12.004 · Cited by 112 · see citing works

Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: A case-control study

Reddy, S. K., Marsh, J. W., Varley, P. R., Mock, B. K., Chopra, K. B., Geller, D. A., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25935 · Cited by 112 · see citing works

Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience

Perumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111 · see citing works

Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview

Banerjee, A., Mukherjee, S., & Maji, B. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.04.009 · Cited by 103 · see citing works

Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways

Schattenberg, J. M., Schuchmann, M., & Galle, P. R. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06582.x · Cited by 108 · see citing works

Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease

Tian, Y., Wong, V. W., Chan, H. L., & Cheng, A. S. L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.010 · Cited by 107 · see citing works

Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC

Viganò, L., Conci, S., Cescon, M., Fava, C., Capelli, P., D’Errico, A., Torzilli, G., Tommaso, L. D., Giuliante, F., Vecchio, F. M., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.024 · Cited by 107 · see citing works

Hepatocellular Carcinoma in the Noncirrhotic Liver

Gaddikeri, S., McNeeley, M. F., Wang, C. L., Bhargava, P., Dighe, M., Yeh, M. M., Dubinsky, T. J., Kolokythas, O., & Lalwani, N. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11511 · Cited by 107 · see citing works

Sorafenib: Where Do We Go from Here?

Siegel, A. B., Olsen, S. K., Magun, A. M., & Brown, R. S. (2010) · Hepatology · doi:10.1002/hep.23633 · Cited by 106 · see citing works

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

Tryndyak, V., Latendresse, J. R., Montgomery, B. A., Ross, S. A., Beland, F. A., Rusyn, I., & Pogribny, I. P. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.018 · Cited by 105 · see citing works

Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease

Sun, C., Fan, J., & Qiao, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035161 · Cited by 106 · see citing works

Clinical features and natural history of hepatocellular adenomas: the impact of obesity

Bunchorntavakul, C., Bahirwani, R., Drazek, D., Soulen, M. C., Siegelman, E. S., Furth, E. E., Olthoff, K. M., Shaked, A., & Reddy, K. R. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04772.x · Cited by 105 · see citing works

Obesity-Related Digestive Diseases and Their Pathophysiology

Nam, S. Y. (2016) · Gut and Liver · doi:10.5009/gnl15557 · Cited by 102 · see citing works

Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism

de l’Hortet, A. C., Takeishi, K., Guzman‐Lepe, J., Morita, K., Achreja, A., Popovic, B., Wang, Y., Handa, K., Mittal, A., Meurs, N., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.017 · Cited by 101 · see citing works

Yttrium-90 Radioembolization as a Bridge to Liver Transplantation: A Single-Institution Experience

Tohme, S. T., Sukato, D. C., Chen, H., Amesur, N. B., Zajko, A. B., Humar, A., Geller, D. A., Marsh, J. W., & Tsung, A. (2013) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2013.07.026 · Cited by 98 · see citing works

Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology

Bolshette, N. B., Ibrahim, H., Reinke, H., & Asher, G. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00792-1 · Cited by 99 · see citing works

Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians

Chang, E., Yang, J., Alfaro-Velcamp, T., So, S., Glaser, S., & Gomez, S. (2010) · Cancer Epidemiology, Biomarkers and Prevention · doi:10.1158/1055-9965.epi-10-0863 · Cited by 97 · see citing works

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

Wong, C. R., Nguyen, M., & Lim, J. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i37.8294 · Cited by 98 · see citing works

Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p

Sun, Y., Wang, Q., Zhang, Y., Geng, M., Wei, Y., Liu, Y., Liu, S., Petersen, R. B., Yue, J., Huang, K., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.050 · Cited by 95 · see citing works

Recent trend of clinical features in patients with hepatocellular carcinoma

Nagaoki, Y., Hyogo, H., Aikata, H., Tanaka, M., Naeshiro, N., Nakahara, T., Honda, Y., Miyaki, D., Kawaoka, T., Takaki, S., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00929.x · Cited by 93 · see citing works

Apelin and insulin resistance: Another arrow for the quiver?

Xu, S., Tsao, P. S., & Yue, P. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00132.x · Cited by 83 · see citing works

The evolutionary scenario of hepatocellular carcinoma in Italy: an update

Bucci, L., Garuti, F., Lenzi, B., Pecorelli, A., Farinati, F., Giannini, E. G., Granito, A., Ciccarese, F., Rapaccini, G. L., Marco, M. D., et al. (2016) · Liver International · doi:10.1111/liv.13204 · Cited by 82 · see citing works

Methionine adenosyltransferases in liver cancer

Murray, B., Barbier‐Torres, L., Fan, W., Mato, J. M., & Lu, S. C.-L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4300 · Cited by 82 · see citing works

The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease

Pοlyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181ec5c66 · Cited by 82 · see citing works

Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation

Siegel, A. B., Lim, E. A., Wang, S., Brubaker, W. D., Rodriguez, R. D., Goyal, A., Jacobson, J. S., Hershman, D. L., Verna, E. C., Zaretsky, J., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e31825c58ea · Cited by 78 · see citing works

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

Nderitu, P., Bosco, C., Garmo, H., Holmberg, L., Malmström, H., Hammar, N., Walldius, G., Jungner, I., Ross, P. J., & Hemelrijck, M. V. (2017) · International Journal of Cancer · doi:10.1002/ijc.30818 · Cited by 78 · see citing works

Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice

Shimizu, M., Sakai, H., Shirakami, Y., Yasuda, Y., Kubota, M., Terakura, D., Baba, A., Ohno, T., Hara, Y., Tanaka, T., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0331 · Cited by 77 · see citing works

Emerging Targeted Strategies in Advanced Hepatocellular Carcinoma

Finn, R. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1333632 · Cited by 77 · see citing works

Primary hepatocellular carcinoma and metabolic syndrome: An update

Rahman, R. N. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i9.186 · Cited by 76 · see citing works

Multifaceted roles of HSF1 in cancer

Jiang, S., Tu, K., Fu, Q., Schmitt, D. C., Zhou, L., Lu, N., & Zhao, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3674-x · Cited by 77 · see citing works

Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency

Pogribny, I. P., James, S. J., & Beland, F. A. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100524 · Cited by 75 · see citing works

Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis

Kwak, M., Mehaffey, J. H., Hawkins, R. B., Hsu, A., Schirmer, B. D., & Hallowell, P. T. (2019) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2019.09.006 · Cited by 75 · see citing works

Hepatic Complications of Obesity

Diehl, A. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.12.001 · Cited by 73 · see citing works

AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma

Cheng, J., Huang, T., Li, Y., Guo, Y., Zhu, Y., Wang, Q., Tan, X., Chen, W., Zhang, Y., Cheng, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093256 · Cited by 73 · see citing works

Primary malignant tumours in the non-cirrhotic liver

Lee, D. H., & Lee, J. M. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.08.030 · Cited by 72 · see citing works

Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

Scalera, A., & Tarantino, G. (2014) · PubMed Central · doi:10.3748/wjg.v20.i28.9217 · Cited by 71 · see citing works

Tumours and Tumour-like Lesions of the Liver

Ferrell, L. D., Kakar, S., Terracciano, L., & Wee, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00013-3 · Cited by 71 · see citing works

Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma

Siddique, A., & Kowdley, K. V. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.007 · Cited by 69 · see citing works

The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers

Lai, G. Y., Weinstein, S. J., Albanes, D., Taylor, P. R., McGlynn, K. A., Virtamo, J. R. K., Sinha, R. R., & Freedman, N. D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.405 · Cited by 70 · see citing works

Metabolic syndrome and liver-related events: a systematic review and meta-analysis

Ren, H., Wang, J., Gao, Y., Yang, F., & Huang, W. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0366-3 · Cited by 70 · see citing works

Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors

Pluimakers, V. G., van Waas, M., Neggers, S. J. C. M. M., & van den Heuvel‐Eibrink, M. M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.10.010 · Cited by 68 · see citing works

Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly

Chiang, C., Lee, L., Hung, S.-H., Lin, C., Hung, H.-F., Yang, W., Sung, P.-K., & Huang, K. (2014) · Hepatology · doi:10.1002/hep.27014 · Cited by 67 · see citing works

Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma

Mazzocca, A., Dituri, F., Santis, F. D., Filannino, A., Lopane, C., Betz, R. C., Li, Y.-Y., Mukaida, N., Winter, P., Tortorella, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1607 · Cited by 66 · see citing works

The Influence of Diabetes in the Pathogenesis and the Clinical Course of Hepatocellular Carcinoma: Recent Findings and New Perspectives

Facciorusso, A. (2013) · Current Diabetes Reviews · doi:10.2174/15733998113099990068 · Cited by 66 · see citing works

Nationwide Study of 4741 Patients With Non-B Non-C Hepatocellular Carcinoma With Special Reference to the Therapeutic Impact

Utsunomiya, T., Shimada, M., Kudo, M., Ichida, T., Matsui, O., Izumi, N., Matsuyama, Y., Sakamoto, M., Nakashima, O., Ku, Y., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31829291e9 · Cited by 65 · see citing works

Prospective Investigation of Serum Metabolites, Coffee Drinking, Liver Cancer Incidence, and Liver Disease Mortality

Loftfield, E., Rothwell, J. A., Sinha, R. R., Keski‐Rahkonen, P., Robinot, N. R., Albanes, D., Weinstein, S. J., Derkach, A., Sampson, J. N., Scalbert, A., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz122 · Cited by 64 · see citing works

Oral Branched-Chain Amino Acid Granules Reduce the Incidence of Hepatocellular Carcinoma and Improve Event-Free Survival in Patients with Liver Cirrhosis

Hayaishi, S., Chung, H., Kudo, M., Ishikawa, E., Takita, M., 上田, 泰., Kitai, S., Inoue, T., Yada, N., Hagiwara, S., et al. (2011) · Digestive Diseases · doi:10.1159/000327571 · Cited by 64 · see citing works

Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study

Lin, X., Shi, K., You, J., Liu, W., Luo, Y., Wu, F.-L., Chen, Y., Wong, D. K.-H., Yuen, M., & Zheng, M. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3157-y · Cited by 64 · see citing works

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

Chávez-Tapia, N. C., Gall, S. M.-B., Ordóñez-Vázquez, A. L., Nuño‐Lámbarri, N., Vidal‐Cevallos, P., & Uribe, M. (2022) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s283840 · Cited by 23 · see citing works

Primary hepatocellular carcinoma and metabolic syndrome: An update

Rahman, R. N. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i9.186 · Cited by 76 · see citing works

Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?

Rosmorduc, O. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.02.008 · Cited by 12 · see citing works

Metabolic Syndrome and Liver Cancer

Jaffe, A., & Strazzabosco, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_51

Metabolic syndrome and hepatocellular carcinoma: an advance in epidemiology study

Zhao, J., & Gao, C. (2010) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2010.00425